| Name | Title | Contact Details |
|---|
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning `neural-dust` technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.
At LivaNova we strive to help where it really counts, where it truly matters the most. Where every single effort, of each one of us, is transformational and expected to leave a lasting mark. That is why at LivaNova we make each innovation count: global, accessible, relevant and breakthrough. Transforming medical innovation into meaningful solutions, into a sustainable healthcare system and ultimately into healthier and – importantly - better lives.
nechealth is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salk is a Brookline, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.